Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Genitourinary 3Head & Neck 2Gastrointestinal 2Sarcoma 1Other solid neoplasm 1NET 1Gynecologic 1Endocrine 1Dermatologic 1CNS 1Breast 1

Conditions

Gastrointestinal Stromal Tumors 17Sarcoma 6Sarcoma, Ewing 5Osteosarcoma 5Neoplasm Metastasis 4Rhabdomyosarcoma 3Colorectal Neoplasms 3Mesothelioma, Malignant 2Hemangiosarcoma 2Chondrosarcoma 2Bone Neoplasms 2Wilms Tumor 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thymoma 1Tertiary Lymphoid Structures 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Piebaldism 1Patient Compliance 1Pathologic Complete Response 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasms 1Melanoma 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1

Interventions

Nivolumab 5Magnetic Resonance Spectroscopy 5Specimen Handling 4pembrolizumab 2Ipilimumab 2Immunoglobulin G 2tislelizumab 1temsirolimus 1spartalizumab 1sargramostim 1regorafenib 1pemigatinib 1eribulin 1cabozantinib 1brivanib 1avelumab 1X-Rays 1Valproic Acid 1Sirolimus 1Radiosurgery 1Mifepristone 1Fluorodeoxyglucose F18 1FAPI-46 1Docetaxel 1Disulfides 1Cyclophosphamide 1Cryosurgery 1Colony-Stimulating Factors 1Clinical Trials, Phase II as Topic 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Transitional Cell × regorafenib × Sarcoma × Clear all
NCT03475953 2023-03-03

REGOMUNE

Institut Bergonié

Phase 1/2 Unknown
747 enrolled
BreastEndocrineGastrointestinalGenitourinaryHead & NeckNETOther solid neoplasmSarcomaThoracic

Gastro-enteropancreatic neuroendocrine tumor, Turcot syndrome, Tertiary Lymphoid Structures, Mesothelioma, Malignant, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡